Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Outlook 2026–2030 Highlighting Innovation Trends and Competitive Landscape
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market At The End Of The 2026–2030 Forecast Period?
The market for artificial intelligence (AI) in in vitro diagnostics (IVD) has seen considerable expansion recently. It is projected to increase from $3.04 billion in 2025 to $3.6 billion in 2026, at a compound annual growth rate (CAGR) of 18.4%. The historical growth of this market can be attributed to factors such as an escalating demand for precise diagnostics, the expansion of laboratory infrastructure, a higher prevalence of chronic diseases, the integration of digital diagnostic instruments, and progress in biomarker research.
The artificial intelligence (ai) in in vitro diagnostics (ivd) market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $7.01 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 18.1%. This anticipated growth during the forecast period is primarily driven by factors such as the proliferation of cloud-based diagnostic platforms, the convergence of AI with genomics, advancements in point-of-care AI diagnostics, increased capital allocation towards personalized medicine, and a heightened need for swift and economical testing solutions. Key trends foreseen for this period encompass AI-driven laboratory automation, predictive disease identification, interpretation of tests through data analysis, widespread adoption of cloud-based diagnostic platforms, and individualized patient profiling.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
The escalating need for individualized healthcare is anticipated to fuel the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market moving forward. Personalized medicine defines a healthcare methodology that customizes prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. This approach is gaining traction as advancements in genomic data and sequencing technologies enable more precise, targeted, and effective treatments tailored to each patient. Artificial intelligence (AI) in in vitro diagnostics (IVD) contributes to personalized medicine by analyzing complex diagnostic data to identify patient-specific disease patterns, thereby facilitating accurate, timely, and customized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. The newly approved personalized treatments for 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Therefore, the growing demand for personalized medicine is a significant driver of the artificial intelligence (AI) in in vitro diagnostics (IVD) market’s growth.
What Segment Types Make Up The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
The artificial intelligence (ai) in in vitro diagnostics (ivd) market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning
3) By Deployment Model: Cloud-Based, On-Premise, Hybrid
4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers
Subsegments:
1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems
2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices
3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education
Which Market Trends Are Creating New Opportunities In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
Major companies operating in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are concentrating on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms. These initiatives aim to improve diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform is defined as an AI system for in vitro diagnostics that meets EU regulatory standards and offers clear, auditable, and understandable decision-making. For example, in May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, an intelligent solution crafted to accelerate and enhance PCR diagnostics. This system automates and speeds up the interpretation of real-time PCR diagnostics with over 99.9% accuracy. It ensures transparency by clearly demonstrating how each result is obtained, thereby securing regulatory compliance and boosting clinical trust. This development significantly improves laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.
Who Are The Key Players Driving Competition In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj
Read the full artificial intelligence (ai) in in vitro diagnostics (ivd) market report here:
Which Regions Are Projected To Dominate The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In The Coming Years?
North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company
Artificial Intelligence In The Diagnostic Market Report 2026
Ai In Cancer Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report
Ai In Medical Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model